Inventor · disambiguated record
Vikram Khetani
Also filed as: KHETANI VIKRAM
10 granted patents·13 pending applications·149 citations·filing 1994–2016
89Inventor score
Top patents by PatentIndex Score
23 records- 0193US7115631B2Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidateCELGENE CORP·Filed 2002·Granted Oct 3, 2006·39 cites·56 claims
- 0291US6486177B2Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidateCELGENE CORP·Filed 2001·Granted Nov 26, 2002·31 cites·46 claims
- 0386US6359139B1Methods for production of piperidyl acetamide stereoisomersCELGENE CORP·Filed 2000·Granted Mar 19, 2002·19 cites·21 claims
- 0479US7459560B2Processes and intermediates for resolving piperidyl acetamide stereoisomersCELGENE CORP·Filed 2006·Granted Dec 2, 2008·2 cites·8 claims
- 0579US5936091AProcesses and intermediates for resolving piperidyl acetamide stereoisomersCELGENE CORP·Filed 1997·Granted Aug 10, 1999·27 cites·9 claims
- 0674US5965734AProcesses and intermediates for preparing 2-substituted piperidine stereoisomersCELGENE CORP·Filed 1997·Granted Oct 12, 1999·20 cites·23 claims
- 0770US2010093797A1Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo MethylphenidateZELDIS JEROME B·Filed 2009·Application pending·0 cites
- 0869US6962997B1Process and intermediates for resolving piperidyl acetamide steroisomersCELGENE CORP·Filed 1999·Granted Nov 8, 2005·11 cites·12 claims
- 0964US2013158073A1Methods Of Diminishing Co-Abuse PotentialKHETANI VIKRAM·Filed 2013·Application pending·0 cites
- 1063US2009062336A1Methods of Diminishing Co-Abuse PotentialCELGENE CORP·Filed 2008·Application pending·0 cites
- 1162US2012136028A1Methods Of Diminishing Co-Abuse PotentialKHETANI VIKRAM·Filed 2012·Application pending·0 cites
- 1261US2013053414A1Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidateZELDIS JEROME B·Filed 2012·Application pending·0 cites
- 1359US2006183774A1Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidateCELGENE CORP·Filed 2006·Application pending·0 cites
- 1458US2011257227A1Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo MethylphenidateZELDIS JEROME B·Filed 2011·Application pending·0 cites
- 1557US2004204456A1Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidateCELGENE CORP·Filed 2004·Application pending·0 cites
- 1655US2016289188A1Compositions and methods for the treatment of viral diseases with pde4 modulatorsCELGENE CORP·Filed 2014·Application pending·0 cites
- 1755US2005239830A1Methods of diminishing co-abuse potentialKHETANI VIKRAM·Filed 2004·Application pending·0 cites
- 1851US2005014790A1Processes and intermediates for resolving piperidyl acetamide stereoisomersCELGENE CORP·Filed 2004·Application pending·0 cites
- 1950US10682336B2PDE4 modulators for treating and preventing immune reconstitution inflammatory syndrome (IRIS)CELGENE CORP·Filed 2016·Granted Jun 16, 2020·0 cites·23 claims
- 2050US2006127421A1Treatment using D-threo methylphenidateCELGENE CORP·Filed 2005·Application pending·0 cites
- 2144US2011118310A1Treatment Using D-Threo MethylphenidateCELGENE CORP·Filed 2011·Application pending·0 cites
- 2239US10001483B2Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkersCELGENE CORP·Filed 2016·Granted Jun 19, 2018·0 cites·29 claims
- 2330US5468865AStereopreferential synthesis of 3-(1-phenylprop-2-yl)-5-phenyloxazolidinonesCELGENE CORP·Filed 1994·Granted Nov 21, 1995·0 cites·21 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →